Sanofi
7,349 posts
Sanofi
@sanofi
An R&D driven, AI-powered biopharma company committed to improving lives and delivering compelling growth. Terms for interactions: bit.ly/sanofi-terms
#NEWS: The @EU_Commission has approved our medicine for the treatment of certain people with secondary progressive #MultipleSclerosis , reinforcing our commitment to advancing scientific innovation that address unmet patient needs. Learn more ⬇️ sanofi.com/en/media-room/…
- The Ministry of Health, Labour and Welfare in Japan has approved our subcutaneous therapy in combination with approved standard-of-care regimens for the treatment of multiple myeloma. Read the full announcement here: sanofi.com/en/media-room/…
- We’re back at #VivaTech 2026, and we’re raising the bar on what AI can do for global health. Visit us June 17 – 20 at Booth 1D01 to see how our teams are accelerating breakthroughs across everything from research and development to manufacturing and supply, driving faster,
- The @US_FDA granted accelerated approval for a treatment for #Type1Diabetes. Learn more: spkl.io/60117DB2R
- With the approval from the @EU_Commission, our subcutaneous multiple myeloma (MM) therapy is now authorized across all existing IV indications for MM in the EU. Read more: sanofi.com/en/media-room/…
